The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSECN.L Regulatory News (SECN)

  • There is currently no data for SECN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Commencement of Buy-back

17 Feb 2022 07:00

RNS Number : 9170B
SEC Newgate S.p.A.
17 February 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM, THE UNITED STATES, NEW ZEALAND, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR INTO ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW THIS ANNOUNCEMENT DOES NOT CONSTITUTE PERSONAL ADVICE FOR THE PURPOSES OF THE CORPORATIONS ACT 2001 (CTH). THE COMPANY DOES NOT HOLD AN AUSTRALIAN FINANCIAL SERVICES LICENCE AND IS NOT LICENSED TO PROVIDE FINANCIAL PRODUCT ADVICE IN RELATION TO ITS ORDINARY SHARES

17 February 2022

 

SEC Newgate S.p.A. ("SEC Newgate" or the "Company")

 

Commencement of Buy-back

 

SEC Newgate (AIM:SECN), the insight-driven global strategic communications group that works at the nexus of business, politics, communities, markets and media, announces the commencement of a share repurchase plan under the authority to make purchases of its Ordinary Shares, as approved by Shareholders at the Company's annual general meeting held on 10 February 2022.

SEC Newgate will buy-back Ordinary Shares for a period of 90 days. The maximum number of shares that may be repurchased under the share purchase plan is 9,168,882 Ordinary Shares, allowing all Minority Shareholders, who are not participating in the Contribution, to sell their Ordinary Shares. The Buy-back will be carried out at a fixed price of 111.32p per Ordinary Share ("Buy-back Price").

 The Buy-back will take place in two stages:

1. In the Buy-back period before Delisting

SEC Newgate has irrevocably instructed Arden Partners, the Company's broker, to make on-market purchases of the Company's Ordinary Shares up to an aggregate maximum of 5,790,567 Ordinary Shares (such figure excluding the 3,378,315 new SEC Ordinary Shares to be issued post-Delisting and purchased by the Company pursuant to the Inveready Agreement) at a fixed price of 111.32p per share. The programme will be independently managed by Arden, which will make trading decisions independently and without the influence of the Company.

Shareholders wishing to sell Ordinary Shares or CDIs in the on-market Buy-back should contact their broker or financial intermediary.

The Company will announce any market repurchases prior to Delisting no later than 7.30 a.m. on the business day following the day on which the repurchase occurred.

The on-market Buy-back will end on 2 March 2022.

Notwithstanding the price and daily volume restrictions set out in the Commission Delegated Regulation (EU) 2016/1052, purchases by the Company are likely to be made outside of these price and volume restrictions at the Buy-back Price due to the limited liquidity in trading of the Company's Ordinary Shares. Share purchases will take place in open market transactions and may be made from time to time depending on market conditions, share price, trading volume and other factors.

2. In the Buy-back period following Delisting

Should any Minority Shareholders remain in the corporate capital of the Company after completion of the Delisting, the Buy-back will continue post-Delisting (for an overall Buy-back Period of 90 days) by means of a matched bargain facility at the Buy-back Price.

The Company has appointed Asset Match, a firm authorised and regulated by the Financial Conduct Authority, to operate an electronic off-market dealing facility for SEC's Ordinary Shares.

This facility will allow shareholders to sell their Ordinary Shares to the Company in periodic auctions.

The Company will provide further details to Shareholders regarding the structure of the post-Delisting Buy-back and the means to participate in such Buy-back following the Delisting.

Any Ordinary Shares acquired by the Company pursuant to the Buy-back shall either be cancelled or retained in Treasury and eventually disposed of in accordance with the resolution that has been taken by shareholders at the General Meeting.

The Buy-back Period will end on 18 May 2022. After the end of the Buy-back Period the Company may decide to make purchases at different offer prices where the maximum offer price will be no more than 111.32 pence per Ordinary Share.

Capitalised terms used in this announcement shall have the same meaning as set out in the Company's announcement dated 25 January 2022, unless otherwise defined.

Media Enquiries

Fiorenzo Tagliabue (Group CEO)

Tel: +39 335 6008858

tagliabue@secrp.com

Emma Kane (Deputy Group CEO, 

CEO SEC Newgate UK) 

Tel: +44 (0) 7876 338339

emma.kane@secnewgate.co.uk

Sergio Penna (Group CFO)

penna@secrp.com

 

Arden Partners (Nominated Adviser and Broker)

 

Richard Johnson, Ben Christie 

Tel: +44 (0) 20 7614 5900

Notes to Editors

SEC Newgate's focus is on achieving positive outcomes through communications, advocacy and research, helping clients clearly demonstrate their purpose, value, and impact locally, nationally and internationally. Further information is available at the Group's website: www.secnewgate.com Further information on SEC Newgate UK is available at: www.secnewgate.co.uk
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBKABKOBKDQBD
Date   Source Headline
3rd Mar 20225:30 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSTransaction in Own Shares
2nd Mar 20227:00 amRNSTransaction in Own Shares
1st Mar 20227:00 amRNSTransaction in Own Shares
28th Feb 20225:30 pmRNSSec Newgate SPA
28th Feb 20227:00 amRNSTransaction in Own Shares
25th Feb 20221:44 pmRNSHolding(s) in Company
25th Feb 20227:52 amRNSTransaction in Own Shares
24th Feb 20227:00 amRNSTransaction in Own Shares
23rd Feb 20227:00 amRNSTransaction in Own Shares
22nd Feb 20227:00 amRNSHolding(s) in Company
22nd Feb 20227:00 amRNSTransaction in Own Shares
21st Feb 20229:30 amRNSTransaction in Own Shares
18th Feb 20227:30 amRNSTransaction in Own Shares
17th Feb 20227:00 amRNSCommencement of Buy-back
10th Feb 20221:00 pmRNSResult of General Meeting
10th Feb 20227:00 amRNSUpdate re Framework and Contribution Agreement
25th Jan 20227:00 amRNSNotice of General Meeting
19th Jan 202211:28 amRNSProposed AIM trading cancellation and financing
11th Nov 20217:00 amRNSTrading Update
26th Oct 20217:00 amRNSInaugural Global Thought Leadership Report
1st Sep 20217:01 amRNSNewington Vendor Consideration
1st Sep 20217:00 amRNSInterim Results
29th Jul 20217:00 amRNSAcquisition
28th Jun 20217:00 amRNSNew London Offices
10th Jun 20217:00 amRNSAnnual Report
8th Jun 20211:23 pmRNSUpdate re Corporate Nominee Facility
8th Jun 20211:12 pmRNSResult of AGM
28th May 20219:45 amRNSHolding(s) in Company
21st May 20218:14 amRNSIssue of Equity
21st May 20217:00 amRNSAudited Full Year Results
6th May 20217:00 amRNSYear End Trading Update and Notice of Results
22nd Mar 20217:00 amRNSExpansion in Central Eastern Europe
11th Mar 202112:33 pmRNSInvestor Presentation
24th Feb 20217:00 amRNSSEC Newgate UK wins prestigious industry award
2nd Feb 20217:01 amRNSBoard Changes
2nd Feb 20217:00 amRNSTrading Update
29th Jan 20217:00 amRNSDirector Dealing
26th Jan 20219:50 amRNSDirector Dealing
26th Jan 20219:00 amRNSEquity Research Initiation
19th Jan 202110:04 amRNSDirector/PDMR Shareholding
18th Jan 20217:00 amRNSMerger and Rebranding of UK Agencies

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.